WAVEMAN · COMPANY

LMRI · Lumexa Imaging Holdings, Inc.

LIVE

TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

LMRI

Name: Lumexa Imaging Holdings, Inc. (LMRI) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Lumexa Imaging Holdings, Inc.

HEALTHCARE SERVICES · SERVICES-MEDICAL LABORATORIES · CIK 0002071288

SEC FILINGS☆ WATCH

INSIDER NET · 180D

$476.9K

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

+5.1%

XBRL, annual

NET MARGIN

1.0%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net +$476.9K over 180 days

more than 83% of Healthcare Services

CONGRESS

no member of Congress has reported trading it

FUNDS

65 funds added or opened last quarter

below 74% of Healthcare Services

REVENUE

+5.1% year over year (latest quarter)

below 67% of Healthcare Services

MARGIN

1.0% net margin (latest quarter)

more than 52% of Healthcare Services

BUYBACKS

no share repurchases reported

SHORT

2.9% of shares outstanding short · 8.5 days to cover · settled 2026-07-31

below 52% of Healthcare Services

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

65 funds added or opened positions in the latest 13F quarter, of 105 holders.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN -36.6%

-36.6%12M

INSIDER BUY

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders are net buyers of their own stock.

The record shows a net $476.9K bought by insiders over 180 days, 65 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

NTRA CSTL PGNY HIMS WGS PRVA TDOC AVAH GH ADUS SERA BDSX

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Lumexa Imaging Holdings, Inc. insiders bought a net $476.9K of stock across 2 Form 4 purchases and sales, with 2 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

BRODNAX BRETT

Director

BUY

2026-05-19

35,000.0

$253.8K

Cooper Henry Lee

Director

BUY

2026-05-14

30,000.0

$223.2K

2 TRANSACTIONS ON RECORD · THIN RECORD, READ IT AS SUCH

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BROWN ADVISORY INC

5,777,574.0 sh

$65.2M

MASSACHUSETTS FINANCIAL SERVICES CO /MA/

3,453,723.0 sh

$39.0M

Think Investments LP

2,559,501.0 sh

$28.9M

Jupiter Topco LLC

2,151,538.0 sh

$24.3M

BlackRock, Inc.

1,398,112.0 sh

$15.8M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Virtus KAR Health Sciences Fund

$2.6M POSITION · AS OF 2026-03-31

2.9%

F/m Emerald Life Sciences Innovation ETF

$1.3M POSITION · AS OF 2026-02-28

1.4%

Select Health Care Services Portfolio

$6.6M POSITION · AS OF 2026-02-28

0.8%

Putnam Small Cap Value Fund

$2.3M POSITION · AS OF 2026-02-28

0.8%

Putnam VT Small Cap Value Fund

$710.4K POSITION · AS OF 2026-03-31

0.7%

Meridian Growth Fund

$2.4M POSITION · AS OF 2026-03-31

0.5%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK